Monte Rosa Therapeutics, Inc. (GLUE) — SC 13D/A Filings

SC 13D/A Filings (5)

• Versant Venture Capital VI Amends Monte Rosa Therapeutics Stake — Oct 30, 2024 Risk: medium
  Versant Venture Capital VI, L.P. filed an amendment (No. 4) to its Schedule 13D on October 30, 2024, regarding its holdings in Monte Rosa Therapeutics, Inc. The
• Versant Venture Capital VI Amends Monte Rosa Therapeutics Stake — Sep 24, 2024 Risk: medium
  Versant Venture Capital VI, L.P. filed an amendment (No. 3) to its Schedule 13D on September 24, 2024, regarding its holdings in Monte Rosa Therapeutics, Inc. T
• Versant Venture Capital VI Amends Monte Rosa Therapeutics Stake — Aug 12, 2024 Risk: medium
  Versant Venture Capital VI, L.P. filed an amendment (No. 2) to its Schedule 13D on August 12, 2024, regarding its holdings in Monte Rosa Therapeutics, Inc. The
• NEA 17 Amends Monte Rosa Therapeutics Stake Filing — Aug 12, 2024 Risk: medium
  New Enterprise Associates 17, L.P. (NEA 17) filed an amendment (No. 2) to its Schedule 13D on August 12, 2024, regarding its holdings in Monte Rosa Therapeutics
• NEA 17 Amends Monte Rosa Therapeutics 13D Filing — May 13, 2024 Risk: low
  New Enterprise Associates 17, L.P. (NEA 17) filed an amendment to its Schedule 13D on May 13, 2024, regarding its holdings in Monte Rosa Therapeutics, Inc. This

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX